These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31403685)

  • 41. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
    Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.
    Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB
    Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.
    Reisinger D; Gojo J; Kasprian G; Haberler C; Peyrl A; Azizi AA; Mayr L; Chocholous M; Kool M; Czech T; Slavc I
    Neurosurgery; 2020 Apr; 86(4):478-484. PubMed ID: 31065705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simplified approach using Taqman low-density array for medulloblastoma subgrouping.
    Cruzeiro GAV; Salomão KB; de Biagi CAO; Baumgartner M; Sturm D; Lira RCP; de Almeida Magalhães T; Baroni Milan M; da Silva Silveira V; Saggioro FP; de Oliveira RS; Dos Santos Klinger PH; Seidinger AL; Yunes JA; de Paula Queiroz RG; Oba-Shinjo SM; Scrideli CA; Nagahashi SMK; Tone LG; Valera ET
    Acta Neuropathol Commun; 2019 Mar; 7(1):33. PubMed ID: 30832734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are the Radiological and Molecular Features of Pediatric Medulloblastomas Valuable Prognostic Indicators? A 10-Year Retrospective Review in the Middle East.
    Alhaj AK; Burhamah T; Mohammad F; Almutawa M; Dashti F; Almurshed M; Behzad S; Snuderl M; Hasan A
    World Neurosurg; 2024 Jul; 187():e156-e165. PubMed ID: 38636638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
    Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medulloblastoma biology in the post-genomic era.
    Archer TC; Pomeroy SL
    Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular progression of SHH-activated medulloblastomas.
    Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Sievers P; Meyer J; Schrimpf D; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; von Deimling A; Kool M
    Acta Neuropathol; 2019 Aug; 138(2):327-330. PubMed ID: 31030238
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas.
    Eberhart CG; Kratz JE; Schuster A; Goldthwaite P; Cohen KJ; Perlman EJ; Burger PC
    Brain Pathol; 2002 Jan; 12(1):36-44. PubMed ID: 11770900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
    Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
    Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The whole-genome landscape of medulloblastoma subtypes.
    Northcott PA; Buchhalter I; Morrissy AS; Hovestadt V; Weischenfeldt J; Ehrenberger T; Gröbner S; Segura-Wang M; Zichner T; Rudneva VA; Warnatz HJ; Sidiropoulos N; Phillips AH; Schumacher S; Kleinheinz K; Waszak SM; Erkek S; Jones DTW; Worst BC; Kool M; Zapatka M; Jäger N; Chavez L; Hutter B; Bieg M; Paramasivam N; Heinold M; Gu Z; Ishaque N; Jäger-Schmidt C; Imbusch CD; Jugold A; Hübschmann D; Risch T; Amstislavskiy V; Gonzalez FGR; Weber UD; Wolf S; Robinson GW; Zhou X; Wu G; Finkelstein D; Liu Y; Cavalli FMG; Luu B; Ramaswamy V; Wu X; Koster J; Ryzhova M; Cho YJ; Pomeroy SL; Herold-Mende C; Schuhmann M; Ebinger M; Liau LM; Mora J; McLendon RE; Jabado N; Kumabe T; Chuah E; Ma Y; Moore RA; Mungall AJ; Mungall KL; Thiessen N; Tse K; Wong T; Jones SJM; Witt O; Milde T; Von Deimling A; Capper D; Korshunov A; Yaspo ML; Kriwacki R; Gajjar A; Zhang J; Beroukhim R; Fraenkel E; Korbel JO; Brors B; Schlesner M; Eils R; Marra MA; Pfister SM; Taylor MD; Lichter P
    Nature; 2017 Jul; 547(7663):311-317. PubMed ID: 28726821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APC mutations in sporadic medulloblastomas.
    Huang H; Mahler-Araujo BM; Sankila A; Chimelli L; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 2000 Feb; 156(2):433-7. PubMed ID: 10666372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
    Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
    J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-MYC expression in medulloblastoma and its prognostic value.
    Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
    Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
    Lamont JM; McManamy CS; Pearson AD; Clifford SC; Ellison DW
    Clin Cancer Res; 2004 Aug; 10(16):5482-93. PubMed ID: 15328187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
    Wang C; Yun Z; Zhao T; Liu X; Ma X
    Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
    Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
    J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutations target distinct subgroups of medulloblastoma.
    Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
    Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.
    Sarkar C; Pramanik P; Karak AK; Mukhopadhyay P; Sharma MC; Singh VP; Mehta VS
    J Neurooncol; 2002 Aug; 59(1):49-61. PubMed ID: 12222838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.